AnGes, Inc.

AnGes, Inc.verified

AMGXF

Price:

$0.3602

Market Cap:

$25.48B

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and disc degeneration; medical devices for the prevention of vascular restenosis; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative r...[Read more]

Industry

Biotechnology

IPO Date

2017-07-03

Stock Exchange

OTC

Ticker

AMGXF

The ROE as of December 2025 (TTM) for AnGes, Inc. (AMGXF) is -369.09%

According to AnGes, Inc.’s latest financial reports and current stock price. The company's current ROE is -369.09%. This represents a change of 33.26% compared to the average of -276.97% of the last 4 quarters.

AnGes, Inc. (AMGXF) Historical ROE (quarterly & annually)

How has AMGXF ROE performed in the past?

The mean historical ROE of AnGes, Inc. over the last ten years is -182.49%. The current -369.09% ROE has changed 102.25% with respect to the historical average. Over the past ten years (40 quarters), AMGXF's ROE was at its highest in in the September 2023 quarter at 0.11%. The ROE was at its lowest in in the December 2024 quarter at -972.73%.

Quarterly (TTM)
Annual

Average

-182.49%

Median

-43.55%

Minimum

-1304.33%

Maximum

-12.88%

AnGes, Inc. (AMGXF) ROE by Quarter and Year

Discovering the peaks and valleys of AnGes, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.48%

Maximum Annual ROE = -12.88%

Minimum Annual Increase = -62.73%

Minimum Annual ROE = -1304.33%

Quarterly (TTM)
Annual
YearROEChange
2024-1304.33%4.48%
2023-28.49%-41.09%
2022-48.36%36.63%
2021-35.40%174.80%
2020-12.88%-58.60%
2019-31.11%-19.69%
2018-38.74%-62.73%
2017-103.94%-15.80%
2016-123.45%25.78%
2015-98.15%220.42%

AnGes, Inc. (AMGXF) Average ROE

How has AMGXF ROE performed in the past?

The current ROE of AnGes, Inc. (AMGXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-460.39%

5-year avg

-285.89%

10-year avg

-182.49%

AnGes, Inc. (AMGXF) ROE vs. Peers

How is AMGXF’s ROE compared to its peers?

AnGes, Inc.’s ROE is less than Faron Pharmaceuticals Oy (0.16%), less than Adocia S.A. (180.00%), less than Recce Pharmaceuticals Ltd (533.12%), greater than Planet 13 Holdings Inc. (-41.69%), less than Newron Pharmaceuticals S.p.A. (1.67%), greater than Volpara Health Technologies Limited (-17.60%), greater than Ascentage Pharma Group International (-249.24%), greater than Eupraxia Pharmaceuticals Inc. (-118.64%), less than EKF Diagnostics Holdings plc (8.50%), less than Prescient Therapeutics Limited (0%),

Build a custom stock screener for AnGes, Inc. (AMGXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnGes, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AnGes, Inc. (AMGXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AnGes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is AnGes, Inc.'s ROE?

How is the ROE calculated for AnGes, Inc. (AMGXF)?

What is the highest ROE for AnGes, Inc. (AMGXF)?

What is the 3-year average ROE for AnGes, Inc. (AMGXF)?

What is the 5-year average ROE for AnGes, Inc. (AMGXF)?

How does the current ROE for AnGes, Inc. (AMGXF) compare to its historical average?